Categories AlphaGraphs, Earnings, Retail

American Eagle Outfitters (AEO) Q4 2019 Earnings Snapshot

— American Eagle Outfitters Inc. (NYSE: AEO) reported its fourth quarter 2019 earnings of $0.37 per share vs. $0.36 per share expected.

— Revenue grew by 6% to $1.31 billion vs. $1.27 billion expected. Consolidated comparable sales rose 2% over the prior year quarter.

American Eagle Outfitters (AEO) Q4 2019 earnings infograph

— GAAP EPS of $0.03 declined from $0.43 in the fourth quarter of 2018.

— Based on an anticipated comparable sales increase in the low single digits, first quarter 2020 EPS is expected to be approximately $0.20 to $0.22.

— The company incurred impairment, restructuring and related charges of approximately $76 million pre-tax, or $0.34 per share after-tax.

— Approximately $65 million of the pre-tax charges related to the non-cash impairment of 20 stores and the remainder primarily reflected severance and other costs.

— American Eagle ended 2019 with a total of 1,095 stores. During FY19, the company opened 27 AE stores and closed 21, ending the year with 940 AE stores.

— AEO stock rose about 7% during the after-hours trading session.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

PM Earnings: Key quarterly highlights from Philip Morris Q3 financial results

Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to

Halliburton stock slips on weaker-than-expected Q3 results

Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top